Aripiprazole Pharmacokinetics (PK) and Tolerability Study in Children and Adolescents
NCT00102479 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2006-04-17
Summary
The purpose of this trial is to assess the safety, tolerability and pharmacokinetics of aripiprazole tablets following oral administration to children and adolescents.
Conditions
Interventions
- DRUG
-
Aripiprazole
Sponsors & Collaborators
-
Otsuka Pharmaceutical Development & Commercialization, Inc.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
Eligibility
- Min Age
- 10 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-07-31
- Completion
- 2005-07-31
More Related Trials
-
Open-Label Observational Pilot Study to Evaluate the Pharmacokinetics of Aripiprazole in Subjects With Bipolar 1 Disorder or Schizophrenia
NCT02050854 ·Status: COMPLETED
-
An Open-Label Trial of Aripiprazole in Children and Adolescents With Bipolar Disorder
NCT00221416 ·Status: COMPLETED ·Phase: PHASE3
-
Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Tourette's Syndrome
NCT03487783 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
NCT01727713 ·Status: COMPLETED ·Phase: PHASE3
-
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group-comparison Trial of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode
NCT00606281 ·Status: COMPLETED ·Phase: PHASE3
-
Aripiprazole in Children and Adolescents With Chronic Tic Disorder or Tourette's Disorder
NCT00706589 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Aripiprazole (Abilify) in Children With Symptoms of Mania
NCT00194077 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD).
NCT00332241 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolar 1 Disorder
NCT04030143 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depression Episode
NCT00080314 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial of Single- and Multiple-doses of Aripiprazole in Adult Subjects With Schizophrenia or Bipolar I Disorder
NCT03854409 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)
NCT00337571 ·Status: COMPLETED ·Phase: PHASE3
-
A Multicenter, Placebo-controlled, Double-blind Investigative Extension Trial of the Safety and Efficacy of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode
NCT00606177 ·Status: COMPLETED ·Phase: PHASE3
-
Open Label Trial of Aripiprazole in Children and Adolescents With Tourette's Disorder
NCT00241176 ·Status: COMPLETED ·Phase: PHASE4
-
A Multicenter Investigative Study of the Safety and Efficacy of Long-term Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode
NCT00606229 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
NCT01727700 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Aripiprazole in Patients With Bipolar I Disorder
NCT00257972 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients
NCT01567527 ·Status: COMPLETED ·Phase: PHASE3
-
Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Autistic Disorder
NCT03487770 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Aripiprazole in Patients With Major Depressive Disorder
NCT00105196 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD)
NCT00365859 ·Status: COMPLETED ·Phase: PHASE3
-
Aripiprazole Once-Monthly in Hospitalized Patients (INITIATE)
NCT04907279 ·Status: UNKNOWN
-
Aripiprazole for Schizophrenia Outpatients Completing BMS Clinical Trials
NCT00239356 ·Status: COMPLETED ·Phase: PHASE3
-
Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
NCT01710709 ·Status: COMPLETED ·Phase: PHASE3
-
Aripiprazole in Children and Adolescents With Bipolar Disorder and Attention Deficit Hyperactivity Disorder (ADHD)
NCT00116259 ·Status: COMPLETED ·Phase: NA